Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.746 USD | +5.65% | 0.00% | -91.13% |
11/04 | US Equity Markets Close Mixed After March Producer Price Inflation Data | MT |
11/04 | Top Midday Decliners | MT |
Business Summary
Number of employees: 40
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marvin White
CEO | Chief Executive Officer | 61 | 01/16/01 |
Daphne Taylor
DFI | Director of Finance/CFO | 57 | 01/16/01 |
Dirk Huebner
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
Jeffrey Lamothe
COO | Chief Operating Officer | 58 | 01/16/01 |
Miriam Miller
IRC | Investor Relations Contact | - | - |
SoYoung Kwon
LAW | General Counsel | 56 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marvin White
CEO | Chief Executive Officer | 61 | 01/16/01 |
Director/Board Member | 69 | 01/16/01 | |
Director/Board Member | 80 | 01/16/01 | |
John Niederhuber
CHM | Chairman | 85 | 22/16/22 |
Director/Board Member | 66 | 22/16/22 | |
Grady Grant
BRD | Director/Board Member | 68 | 01/16/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,594,058 | 3,589,975 ( 99.89 %) | 0 | 99.89 % |
Company contact information
Aptevo Therapeutics, Inc.
2401 4th Avenue Suite 1050
98121, Seattle
+206 838 0500
http://www.aptevotherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-91.13% | 1.13M | |
-2.65% | 103B | |
+1.58% | 95.28B | |
+1.46% | 22.15B | |
-15.56% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.96% | 16.05B | |
+5.18% | 13.68B | |
+33.60% | 12.17B |
- Stock Market
- Equities
- APVO Stock
- Company Aptevo Therapeutics Inc.